Table 3.
SNP Name | Nonhierarch. Arlequinc F ST (p < .01) | BayeScand F ST (q < 0.05) | All three Arlequin F ST methodse | Hierarch. Arlequinf F CT (p < .01) | Chrg on NA Maph | Position NA maph (cM) | Chrg on EU maph | Position EU maph (cM) | %seq. similarity | Genome position (transcript)i | E‐value | Matches (Gene or Protein) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ESTV_15118_153 | √ | 1 | 13.7 | 1 | 94.9 | 70% | CIGSSA_003028.t4 | 1E‐75 | Mitochondrial ribosomal protein s5 | |||
ESTNV_16380_81 | √ | 3 | 11.5 | 3 | 0.9 | 99% | CIGSSA_119709.t2 | 2E‐125 | WW domain‐containing adapter protein with coiled‐coil‐like isoform X2 | |||
GCR_cBin8095_Ctg1_103k | 3 | 103.2 | 3 | 87.2 | 99% | CIGSSA_018951.t1 | 4E‐138 | Protein phosphatase 1 regulatory subunit 1B‐like | ||||
ESTNV_36457_2447 | √ | √ | 4 | 0 | 4 | 6.1 | 99% | CIGSSA_024082.t6 | 0 | Protogenin B‐like isoform X1 | ||
ESTNV_35352_77 | √ | √ | 4 | 101.6 | 4 | 109.9 | 72% | CIGSSA_024847.t1 | 1E‐163 | RPA‐interacting protein rpain‐a | ||
GCR_hBin33595_Ctg1_191 | √ | √ | √ | 6 | 7.9 | – | – | 98% | CIGSSA_032258.t2 | 1E‐10 | ATPase family AAA domain protein 5‐like isoform X1 | |
ESTV_16674_300 | 6 | 63.7 | – | – | 100% | CIGSSA_034497.t1 | 3E‐14 | Zona pellucida sperm‐binding protein 4‐like | ||||
ESTNV_33402_1114 | √ | 6 | 67.4 | 6 | 66 | 100% | CIGSSA_032952.t1 | 0 | Cleavage and polyadenylation specificity factor subunit 3 | |||
ESTNV_34703_1491 | √ | √ | 9 | 67.4 | 9 | 52.7 | 100% | CIGSSA_042894.t2 | 0 | HCLS1‐binding protein 3 | ||
ESTNV_17881_371 | √ | √√ | 9 | 96.2 | 9 | 91.9 | 99% | XM_014214565 | 0 | Protein phosphatase, Mg2+/Mn2+ dependent | ||
ESTNV_24797_128 | √ | √ | √ | 12 | 38.0 | 12 | 68.7 | 61.6% | CIGSSA_063980.t1 | 3.41E‐27 | MHC class ii alpha chain | |
ESTNV_16810_167 | √ | √ | √ | 12 | 70.4 | 12 | 108.3 | 99.8% | CIGSSA_062376.t1 | 0 | CD34b1 | |
ESTNV_27237_290 | √ | 13 | 37.1 | – | – | 94% | CIGSSA_069043.t1 | 2.39E‐66 | Orm1‐like protein 2 | |||
ESTNV_22997_260 | √ | √ | √ | 13 | 52 | 13 | 85 | 97% | XM_014138527.1 | 0 | RILP‐like protein 1 (LOC106568309), transcript variant X4, | |
ESTNV_28880_179 | √ | √ | 14 | – | 14 | 62 | 100% | CIGSSA_073641.t4 | 2E‐151 | Probable 39S ribosomal protein L24, mitochondrial isoform X1 | ||
ESTNV_29368_168 | √ | 15 | 34.9 | 15 | 44.2 | 83% | CIGSSA_079971.t5 | 2.00E‐161 | Translocation associated membrane protein 2 | |||
ESTNV_34978_699 | √ | √ | 16 | 42.9 | 16 | 43.5 | 100% | CIGSSA_085177.t1 | 4E‐102 | Glycine cleavage system H protein, mitochondrial‐like | ||
ESTV_14714_122 | √ | √ | √ | 19 | 61.5 | 19 | 52.7 | 98% | XM_014158407.1 | 0.0 | Zinc transporter ZIP11‐like transcript variant X2, mRNA | |
ESTNV_31104_129 | √ | 20a | –a | 20 | 46.2 | 100% | CIGSSA_101213.t1 | 3E‐45 | Rab5 gdpgtp exchange factor | |||
ESTNV_28135_402 | √ | √ | 22 | 58.2 | 22 | 48.5 | 100% | CIGSSA_109518.t2 | 1E‐26 | Claudin‐19 isoform X2 | ||
ESTNV_28135_544 | √ | √ | 22 | 58.2 | 22 | 48.5 | 100% | CIGSSA_109518 | 1E‐26 | Claudin‐19 isoform X2 | ||
ESTNV_31411_621 | √ | 22 | 44.5 | 22 | 35.4 | 100% | CIGSSA_108471.t1 | 1E‐92 | DNA‐binding protein inhibitor ID‐1 | |||
ESTNV_31110_261j | √ | 1/23 | 63.3 | 23 | 13.2 | 91% | CIGSSA_112247.t1 | 2E‐26 | Thrombopoietin receptor‐like | |||
ESTNV_31110_721j | √ | 1/23 | 63.3 | 23 | 13.2 | 91% | CIGSSA_112247.t1 | 2E‐26 | Thrombopoietin receptor‐like | |||
ESTNV_31210_275l | √ | √ | 1/23 | 118.1 | 23 | 51.4 | 87% | CIGSSA_112663.t1 | 0 | Palmitoyltransferase ZDHHC7‐like isoform X1 | ||
ESTNV_35075_2399 | √ | √ | 25 | 73 | 25 | 52.7 | 92% | CIGSSA_117588.t3 | 0 | Type I inositol 3,4‐bisphosphate 4‐phosphatase‐like isoform X3 | ||
ESTNV_25950_262 | √ | 26/28 | 49.6 | 26 | 22.9 | 81% | CIGSSA_119802.t1 | 4E‐140 | Phosphatidylinositol 3‐kinase regulatory subunit alpha‐like |
p < .001.
After individuals shown by STRUCTURE to have European subspecies ancestry had been removed from the dataset.
Non‐hierarchical Arlequin outlier analysis (Appendix S1) was done using the nonhierarchical option and included five AQUA populations: 2010PG_AQUA, (2011PG_AQUA + 2011PGN_AQUA), 2012PG_AQUA as well as the TOB_WILD population.
BayeScan analysis (Figure 2; Appendix S2) is always nonhierarchical and included five AQUA populations: 2009PO_AQUA, 2010PG_AQUA, 2011PG_AQUA, 2011PGN_AQUA, 2012PG_AQUA, as well as the TOB_WILD population.
Hierarchical Arlequin outlier analysis (Appendix S5) was performed using the hierarchical option. The three large populations of AQUA populations (2010PG, {2011PG + 2011PGN}, and 2012 PG) were placed in one group, and the TOB_WILD population was randomly split into two random populations (see text) and placed in a second group.
Significant F ST (p < .01) in three methods of Arlequin analysis including in at least one of the pairwise comparisons (Figure 2; Appendix S3).
“Chr” means the chromosome number on which the outlier locus was located.
“NA” means the position on the North American Atlantic salmon female linkage map by Brenna‐Hansen et al. (2012); “EU” means the position on the European Atlantic salmon female linkage map by Lien et al. (2011).
Genome position is shown as the reference transcript name and number containing the SNP where possible as numbering of the base pairs may change in subsequent releases of Atlantic salmon (Salmo salar) genome.
“√” means the significance value is smaller than the significance level (see text) for that method.
These two SNPs are 460 base pairs apart on in the same mRNA transcript and, consequently, were in perfect linkage disequilibrium with each other.
This SNP is also an outlier locus for nonhierarchical and hierarchical comparisons of the Stewiacke populations with the AQUA populations.
Chromosome containing a SNP inferred from European map (Lien et al., 2011) after known translocations were accounted for (Brenna‐Hansen et al., 2012); consequently, the exact position on the North American chromosome is unknown.
ESTNV_31210_275 codes for a protein that plays a role in follicle stimulating hormone activation of testicular Sertoli cells (Pedram et al. 2012).